Sanofi's Net Worth
$7.84 Billion
Who is Sanofi?
Sanofi has an estimated net worth of $7.84 Billion. This is based on reported shares across multiple companies, which include Translate Bio, Inc., Icosavax, Inc., Inozyme Pharma, Inc., Fulcrum Therapeutics, Inc., Voyager Therapeutics, Inc., MyoKardia Inc, SCYNEXIS INC, ALNYLAM PHARMACEUTICALS, INC., , Regulus Therapeutics Inc., KALOBIOS PHARMACEUTICALS INC, GENZYME CORP, CHATTEM INC, REGENERON PHARMACEUTICALS INC, IDM PHARMA, INC., and MeiraGTx Holdings plc.
SEC CIK
Sanofi's CIK is 0001121404
Past Insider Trading and Trends
2021 was Sanofi's most active year for acquiring shares with 2 total transactions. Sanofi's most active month to acquire stocks was the month of August. 2019 was Sanofi's most active year for disposing of shares, totalling 2 transactions. Sanofi's most active month to dispose stocks was the month of February. 2021 saw Sanofi paying a total of $2,735,376,686.00 for 71,983,597 shares, this is the most they've acquired in one year. In 2020 Sanofi cashed out on 20,550,813 shares for a total of $10,475,228,357.77, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Translate Bio, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1,953.72% | 71.98M |
$38.00 | $2,735,376,686.00 | 75.67M |
Sep 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Icosavax, Inc. (ICVX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.16M |
$15.00 | $1,000,005.00 | 3.16M |
Aug 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Inozyme Pharma, Inc. (INZY) Snapshot price: $4.98
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 520.13K |
$16.00 | $1,300,000.00 | 520.13K |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Fulcrum Therapeutics, Inc. (FULC) Snapshot price: $8.54
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 558.03K |
$16.00 | $1,500,000.00 | 558.03K |
Jul 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Voyager Therapeutics, Inc. (VYGR) Snapshot price: $6.13
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.48M |
$14.00 | $1,750,000.00 | 2.48M |
Nov 10 - Nov 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||